| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $82.0M | -46.1% |
| R&D Expense | $112.2M | -42.5% |
| SG&A Expense | $46.1M | -12.8% |
| Operating Income | -$76.3M | +20.3% |
| Pre-tax Income | -$65.8M | +18.7% |
| Income Tax | -$4K | +0.0% |
| Net Income | -$65.8M | +18.7% |
| EPS (Basic) | -$2.40 | +20.0% |
| EPS (Diluted) | -$2.40 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $230.9M | -2.6% |
| Accounts Receivable | $5.6M | +40.0% |
| Current Assets | $241.4M | -21.1% |
| Total Assets | $271.1M | -21.2% |
| Current Liabilities | $36.4M | -44.5% |
| Total Liabilities | $57.2M | -44.6% |
| Stockholders' Equity | $214.0M | -11.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$74.3M | -24.3% |
| Capital Expenditures | $230K | -64.5% |
| Investing Cash Flow | -$230K | +64.5% |
| Financing Cash Flow | $13.4M | +147.0% |
| Free Cash Flow | -$74.5M | -23.4% |
| +20.0% |